ALB and hereditary elliptocytosis: Among the studies investigating the therapeutic role of albumin infusion, Simon-Talero et al. reported a poor therapeutic effect of albumin infusion on HE (but with a significant improvement in 90 day survival) [25], but several studies suggested that albumin infusion could improve both HE and survival in patients with decompensated liver cirrhosis [26, 27].